Nantahala reports 3.33M shares (5.82%) of Abeona
ABEONA THERAPEUTICS INC. reports amended beneficial ownership by Nantahala Capital Partners.
Rhea-AI Filing Summary
ABEONA THERAPEUTICS INC. reports amended beneficial ownership by Nantahala Capital Partners. As of March 31, 2026, Nantahala may be deemed the beneficial owner of 3,333,757 shares, representing 5.82% of the class based on 57,049,023 shares outstanding as of December 31, 2025. The reported total includes 179,832 shares that may be acquired within sixty days upon exercise of securities. The filing shows shared voting and dispositive power over the full position.
Positive
- None.
Negative
- None.
Insights
Nantahala reports a 5.82% stake in Abeona, including short‑term exercisable securities.
The filing states Nantahala may be deemed beneficial owner of 3,333,757 shares as of March 31, 2026, based on 57,049,023 shares outstanding as of December 31, 2025. It expressly includes 179,832 shares exercisable within sixty days.
All reported voting and dispositive power is shared for the full amount. Future disclosures or Schedule 13D changes would be required if Nantahala’s intent or control changes.
Key Figures
Key Terms
beneficial owner regulatory
exercisable within sixty days financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Nantahala Capital report in ABEO?
Does the reported stake include options or exercisable securities?
What voting and disposition powers does Nantahala report?
What date anchors the ownership percentages in the filing?
Who signed the amendment on behalf of Nantahala?
AI-generated analysis. How Rhea-AI works. Not financial advice.